Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2010
09/23/2010WO2010069008A9 A germline competent cell derived from adult tissue
09/23/2010WO2010065957A3 Vascularized living skin constructs and methods of use thereof
09/23/2010WO2010065776A3 Identification of neuroprotective agents using pro-inflammatory human glial cells
09/23/2010WO2010060096A3 Compositions and methods for increasing cellulose production
09/23/2010WO2010051204A4 Bcr-abl variants
09/23/2010WO2010026601A3 Vector for identification, selection and expression of recombinants
09/23/2010US20100242140 Modulation Of Plant Cell Wall Deposition
09/23/2010US20100242137 Polynucleotides encoding proteins involved in plant metabolism
09/23/2010US20100242136 Udp-glucose modifiers
09/23/2010US20100242134 Methods and polynucleotides for improving plants
09/23/2010US20100242131 Inbred corn line phehg
09/23/2010US20100242128 Method to produce modified plants with altered n-glycosylation pattern
09/23/2010US20100242125 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals
09/23/2010US20100242123 Models of atherosclerosis, hyperlipidemia, lipoprotein oxidation and blood vessel inflammation and methods for making and using them
09/23/2010US20100241228 Engineered osteochondral construct for treatment of articular cartilage defects
09/23/2010US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells
09/23/2010US20100240866 Modified gherlin peptides
09/23/2010US20100240764 Use of S-Clenbuterol
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240733 Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
09/23/2010US20100240675 Therapeutic agents useful for treating pain
09/23/2010US20100240673 EML4-ALK Fusion Gene
09/23/2010US20100240663 Heterocycles as potassium channel modulators
09/23/2010US20100240630 Compounds and therapeutic uses thereof
09/23/2010US20100240597 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
09/23/2010US20100240589 Diastereomeric peptides useful as inhibitors of membrane protein assembly
09/23/2010US20100240585 In vivo cell surface engineering
09/23/2010US20100240583 Soluble protein and utilization of the same
09/23/2010US20100240542 Kits for multiparametric phospho analysis
09/23/2010US20100240133 Compositions and Methods for Transposon Mutagenesis of Human Embryonic Stem Cells
09/23/2010US20100240132 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
09/23/2010US20100240130 Differentiation and Enrichment of Islet-like Cells from Human Pluripotent Stem Cells
09/23/2010US20100240129 Transfer of Molecules
09/23/2010US20100240128 Modified Gene Silencing
09/23/2010US20100240127 Method of cryopreserving cells
09/23/2010US20100240126 Development of universal cancer drugs and vaccines
09/23/2010US20100240125 Bone delivery conjugates and method of using same to target proteins to bone
09/23/2010US20100240100 Human antibodies that have mn binding and cell adhesion-neutralizing activity
09/23/2010US20100240097 Mammalian expression vector with a highly efficient secretory signal sequence
09/23/2010US20100240096 Novel hemopoietin receptor protein, nr10
09/23/2010US20100240090 Methods and platforms for drug discovery
09/23/2010US20100240058 MicroRNA Antisense PNAs, Compositions Comprising the Same, and Methods for Using and Evaluating the Same
09/23/2010US20100240041 Microfluidic device for trapping single cell
09/23/2010US20100240038 Method of screening a drug such as insulin secretagogue
09/23/2010US20100240034 Gene defects and mutant ALK kinase in human solid tumors
09/23/2010US20100239696 Flaxseed lignan complex, methods of using amd compositions thereof
09/23/2010US20100239671 Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair
09/23/2010US20100239633 Immunoglobulin constant region fc receptor binding agents
09/23/2010US20100239617 Modified rsv f proteins and methods of their use
09/23/2010US20100239597 Anti-ADDL monoclonal antibody and use thereof
09/23/2010US20100239594 Compositions and methods for production of immunoglobulins
09/23/2010US20100239593 Rsv-specific binding molecules and means for producing them
09/23/2010US20100239591 Monoclonal antibody for app
09/23/2010US20100239588 The functional epitope of osteopontin, the anti-osteopontin monoclonal antibody and use thereof
09/23/2010US20100239584 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x
09/23/2010US20100239583 Antibodies against flagellin and uses thereof
09/23/2010US20100239582 Dual Specificity Antibody Fusions
09/23/2010US20100239581 Kidney disease targets and uses thereof
09/23/2010US20100239579 CD47 Related Compositions and Methods for Treating Immunological Diseases and Disorders
09/23/2010US20100239577 Anti-glypican-3 antibody having improved kinetics in plasma
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239575 Anti-cd40 antibodies and uses thereof
09/23/2010US20100239571 CD30 Binding Agents and Uses Thereof
09/23/2010US20100239570 Moncolonal amyloid beta (abeta) - specific antibody and uses thereof
09/23/2010US20100239556 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system
09/23/2010US20100239554 Extended recombinant polypeptides and compositions comprising same
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239548 Isolation and Identification of T Cells
09/23/2010US20100239547 Synthetic hla binding peptide analogues and uses thereof
09/23/2010US20100239546 Bacterial mediated tnf alpha gene silencing
09/23/2010US20100239545 Transfection with nucleic acid; insertion
09/23/2010US20100239544 Methods of treatment using electromagnetic field stimulated stem cells
09/23/2010US20100239543 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
09/23/2010US20100239542 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
09/23/2010US20100239541 Transplantation of human neural cells for treatment of neurodegenerative conditions
09/23/2010US20100239540 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
09/23/2010US20100239539 Methods for promoting differentiation and differentiation efficiency
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239498 Method of maintaining the function of liver tissue cells over long time
09/23/2010CA2755874A1 Polymers for growing cells
09/23/2010CA2755870A1 Production of reprogrammed pluripotent cells
09/23/2010CA2755782A1 Biomarkers and uses thereof
09/23/2010CA2755639A1 Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
09/23/2010CA2753981A1 Novel acetyl-coa carboxylase
09/22/2010EP2230311A1 Components of cell culture media produced from plant cells
09/22/2010EP2230309A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof
09/22/2010EP2230307A1 Neutrokine alpha
09/22/2010EP2230301A1 Novel glucose dehydrogenase
09/22/2010EP2230300A1 Polypeptide having enhanced effector function
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230298A1 Anterior ocular segment related cell sheets, three-dimensional structures, and processes for producing the same
09/22/2010EP2230297A1 Cell culture apparatus and methods of use
09/22/2010EP2230250A1 Anti-hiv monoclonal antibody
09/22/2010EP2230248A1 Method for increasing the pool of Ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass
09/22/2010EP2229956A1 Multimeric constructs
09/22/2010EP2229948A1 Mesenchymal CD34- stem cells for use in diabetes gene therapy
09/22/2010EP2229444A2 Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
09/22/2010EP2229436A1 Protection of progenitor cells and regulation of their differentiation
09/22/2010EP2229435A1 Method for extracellular matrix mediated differentiation and proliferation of stem cells
09/22/2010EP2229434A2 Differentiation of human embryonic stem cells